Skip to main content
Current Pharmaceutical Design publishes timely in-depth reviews covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area. A Guest Editor who is an acknowledged authority in a therapeutic field has solicits for each issue comprehensive and timely reviews from leading researchers in the pharmaceutical industry and academia.

Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design, including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

Publisher: Bentham Science Publishers

More about this publication?
Volume 12, Number 33, 2006

Articles

Favourites:
ADD

Vaccine Development for Alzheimer's Disease
pp. 4283-4293(11)
Authors: DaSilva, Kevin A.; Aubert, Isabelle; McLaurin, JoAnne

Favourites:
ADD

Views on Amyloid Hypothesis and Secretase Inhibitors for Treating Alzheimer's Disease: Progress and Problems
pp. 4295-4312(18)
Authors: Nguyen, Jeffrey-Tri; Yamani, Abdellah; Kiso, Yoshiaki

Favourites:
ADD

Gamma-Secretase as a Pharmacological Target in Alzheimer Disease Research: When, Why and How?
pp. 4313-4335(23)
Authors: Ziani-Cherif, Chewki; Mostefa-Kara, Bachir; Brixi-Gormat, Fatima Z.

Favourites:
ADD

Selective Modulation of Aβ42 Production in Alzheimer's Disease: Non-Steroidal Anti-Inflammatory Drugs and Beyond
pp. 4337-4355(19)
Authors: Leuchtenberger, Stefanie; Beher, Dirk; Weggen, Sascha

Favourites:
ADD
Favourites:
ADD

Targeting Beta-Amyloid Pathogenesis Through Acetylcholinesterase Inhibitors
pp. 4377-4387(11)
Authors: Castro, Ana; Martinez, Ana

Favourites:
ADD

Molecular and Biochemical Features in Alzheimer's Disease
pp. 4389-4408(20)
Authors: Pallas, Merce; Camins, Antoni

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content